2BB score and signals
Tvardi Therapeutics, Inc.’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 41 | Normal |
| Quality | 40 | Normal |
| Risk | 49 | Moderate |
Company facts
| Headquarters | Sugar Land, Texas, United States |
| Founded | 2017 |
| Employees | 12 |
| 52-week range | $1.50 – $43.65 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.5894 | — | $0.00 |
| 2026-08-13 | — | -0.7181 | — | $0.00 |
| 2026-05-08 | -0.73 | -0.7592 | — | $0.00 |
| 2026-03-31 | -0.78 | -0.6592 | $0.00 | $0.00 |
Related companies
